Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × Lenalidomide × Clear all

NCT00975806 2019-11-25

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Phase 1/2 Terminated

16 enrolled 13 charts

Carcinoma, Renal Cell